Author

Bhargavi Ilangovan

Observed names: B. Ilangovan, Dr.Bhargavi Ilangovan

Observed institution: Apollo Hospitals

ORCID: 0000-0002-2731-518X

Observed ORCID: 0000-0002-2731-518X

OpenAlex ID: A5046679815

Long-term outcome of high-dose-rate brachytherapy and perioperative brachytherapy in early mobile tongue cancer

2018 · Mahadev Potharaju, Hemanth Raj, et al. · Journal of Contemporary Brachytherapy · 19

PDF

Volume changes during head-and-neck radiotherapy and its impact on the parotid dose – A single-institution observational study

2020 · Bhargavi Ilangovan, Murali Venkatraman, et al. · Journal of Cancer Research and Therapeutics · 3

Radiotherapy for patients with cardiovascular implantable electronic device-a single institutional experience

2021 · Bhargavi Ilangovan, Murali Venkatraman, et al. · IHJ Cardiovascular Case Reports (CVCR) · 2

Atlas of Sellar, Suprasellar, and Parasellar Lesions

2020 · Narayanan Janakiram, Dharambir S. Sethi, et al. · Thieme Medical and Scientific Publishers Private Limited eBooks · 2

Regaining Vision from No Perception of Light after Radiotherapy for a Case of Suprasellar Meningioma

2014 · Bhargavi Ilangovan, Janos Stumpf, et al. · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · 1

WITHDRAWN: A Decade of Hereditary Cancer Genetic Testing Results in Asian Indian population: Retrospective Study

2026 · Ramesh Menon, Lakshmi Mahadevan, et al. · medRxiv

PDF

Comparative analysis of hereditary cancer genetic testing programs in India and the US: Identifying disparities and guiding global program development.

2026 · Ranjit K. Goudar, Bhargavi Ilangovan, et al. · Journal of Clinical Oncology

Wait-and-Watch Strategy Following Neoadjuvant Chemoradiotherapy for Rectal Cancer: a Prospective Cohort Study from an Indian Tertiary Care Center

2026 · Ayyappan, Bhargavi Ilangovan, et al. · Indian Journal of Surgical Oncology

132eP Real-world impact of BRCA, HRD testing and PARP inhibitor therapy on survival in ovarian cancer: A 5-year single-centre experience from South India

2025 · B. Ilangovan, R. Ganapathy, et al. · ESMO Open

PDF

7eP Comprehensive analysis of hereditary cancer syndromes: A six-year single-institution experience in south India

2025 · V. Selvaraj, B. Ilangovan, et al. · ESMO Open

PDF

An Explorative Study of the Unspoken Grieving Experiences of Bereaved Family Members—An Indian Perspective

2025 · Dhayanandan Shanmugam, S. G. Raman, et al. · Psycho-Oncology

Long and Meaningful Survival of a Case with Disseminated Hemangiopericytoma - Treated with Radiation Alone

2024 · Bhargavi Ilangovan, Janos Stumpf, et al. · Exclusive Real World Evidence Journal

Germline rad 50 mutation in a case with synchronous breast and kidney cancer: a rare case

2023 · Bhargavi Ilangovan, Ganapathy Raman, et al. · Egyptian Journal of Medical Human Genetics

PDF

A Case of Primary Myxoid Liposarcoma of the Heart Masquerading as Massive Pericardial Effusion

2022 · Bhargavi Ilangovan, Ayyappan S, et al. · Exclusive Real World Evidence Journal

165 An audit of the use of vaginal brachytherapy in endometrial cancers

2020 · Bhargavi Ilangovan, Ganapathy Raman, et al. · International Journal of Gynecological Cancer

PDF

An Audit of the Use of Vaginal Brachytherapy in Endometrial Cancers

2020 · Dr.Bhargavi Ilangovan, Swaminathan Ganapathy Raman, et al.

Four Cases of Hemangiopericytoma and the Contribution of Radiotherapy in Their Management

2016 · Bhargavi Ilangovan, Neetu Sasikumar, et al. · Indian Journal of Neurosurgery

Technical considerations in brachytherapy boost for a case of squamous cell carcinoma of the external auditory canal based on our case

2015 · Bhargavi Ilangovan, Janos Stumpf, et al. · Journal of Cancer Research and Therapeutics

Squamous Cell Carcinoma in the Native Kidney of a Renal Transplant Recipient with Urethral Deposit - A Case Report

2012 · Bhargavi Ilangovan, Janos Stumpf, et al. · Apollo Medicine

Works count: 19

Citation count: 27

H-index: 2

I10-index: 1